Elite Pharmaceuticals (ELTP) Other Accumulated Expenses (2017 - 2026)
Elite Pharmaceuticals (ELTP) reported Other Accumulated Expenses of $728,791 for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 87.1% from $389,605 a year earlier and up 47.7% from the prior quarter.
Elite Pharmaceuticals (ELTP) Other Accumulated Expenses (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals posted Other Accumulated Expenses of $619,604, up 113.4% from FY2025.
- Other Accumulated Expenses has a four-year compound annual growth rate of -35.7% (FY2022 to FY2026).
- By fiscal year, Other Accumulated Expenses came in at $290,363 in FY2025 (-49.8%), $578,108 in FY2024 (-86.0%), $4.13 million in FY2023 (+13.8%) and $3.63 million in FY2022.
- The fiscal Q2 2027 figure ranks as the highest quarterly Other Accumulated Expenses since fiscal Q3 2024.
- Year over year, Other Accumulated Expenses gained in five of the last eight quarters, with growth averaging 21.8%.
- The high point for year-over-year Other Accumulated Expenses in five years was fiscal Q4 2026 (growth of 113.4%); the low point was fiscal Q3 2025 (a decline of 95.4%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $493,416 (Q1 2027), $619,604 (Q4 2026) and $403,417 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 728,791.00 |
| Jun 30, 2026 | 493,416.00 |
| Mar 31, 2026 | 619,604.00 |
| Dec 31, 2025 | 403,417.00 |
| Sep 30, 2025 | 389,605.00 |
| Jun 30, 2025 | 610,000.00 |
| Mar 31, 2025 | 290,363.00 |
| Dec 31, 2024 | 318,513.00 |
| Sep 30, 2024 | 315,362.00 |
| Jun 30, 2024 | 324,265.00 |
| Mar 31, 2024 | 578,108.00 |
| Dec 31, 2023 | 6.93 Mn |
| Sep 30, 2023 | 6.41 Mn |
| Jun 30, 2023 | 4.47 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Mar 31, 2022 | 3.63 Mn |
| Dec 31, 2019 | 1.20 Mn |
| Sep 30, 2019 | 1.20 Mn |
Elite Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();